Arena Life Science


Generic name: Apixaban

Pharmacologic Category: Anticoagulant

Dosage Forms: Tablet, Oral (2.5 mg, 5 mg)


Apixaban is a selective inhibitor of FXa. Apixaban inhibits free and clot-bound FXa and indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, apixaban decreases thrombin generation and thrombus development


  • Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation (NVAF)
  • Treatment of deep vein thrombosis (DVT)
  • Treatment of pulmonary embolism (PE)
  • Reduction in the risk of recurrence of DVT or PE 
  • Prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery
  • Apirax® is the first generic form of apixaban in Iran which is produced at a GMP approved manufacturing site


Did you know, if you have AFib not caused by a heart valve problem, you are 5x more likely to have a stroke?

Did you know Apixaban was found to be the safest oral anticoagulant, with reduced risk of major, intracranial and gastrointestinal bleedings?


Product images
  • Apixaban (Apirax 2.5 , 5)
  • Apixaban (Apirax 2.5 , 5)
  • Apixaban (Apirax 2.5 , 5)
  • Apixaban (Apirax 2.5 , 5)
Product sharing
Related products
Click + to add content

Company Address

No 20, 5th Floor , 8th Sharestan , Makoueipour St, Za'feraniyeh, Tehran-Iran

Phone: (+98) 21 26 80 5483 - 21 26 80 5489 - Fax: (+98)21 26 80 5478     Email: